Showing results (1-10 of 315) with videos related to
Sort By:
Pageof 32
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 25, 2003
Etoposide induces chimeric Mll gene fusionsJavier G Blanco, Mathew J Edick, Mary V RellingDrug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donorsVanessa Gonzalez-Covarrubias, Jianping Zhang, James L Kalabus, et al.Toxicology Letters|February 16, 2006
Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whitesVanessa Gonzalez Covarrubias, Sukhwinder S Lakhman, Alan Forrest, et al.Pharmacogenetics|November 20, 2002
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignanciesJavier G Blanco, Mathew J Edick, Michael L Hancock, et al.Cancer Research|May 19, 2007
Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamicsChristine Hartford, Erick Vasquez, Matthias Schwab, et al.Pharmacogenetics and Genomics|April 9, 2014
Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine modelLaura B Ramsey, Laura J Janke, Mathew J Edick, et al.Genes, Chromosomes & Cancer|November 16, 2004
Lymphoid gene expression as a predictor of risk of secondary brain tumorsMathew J Edick, Cheng Cheng, Wenjian Yang, et al.Nature|May 28, 2004
Moving towards individualized medicine with pharmacogenomicsWilliam E Evans, Mary V RellingHematology. American Society of Hematology. Education Program|December 10, 2013
Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacyMary V Relling, Laura B RamseyPageof 32